- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02896348
Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors
The goal of this study is to:
- Assess the usability of the SynPhNe device in a home environment.
- Evaluate the efficacy of the SynPhNe home use device to improve motor hand function in chronic stroke subjects when used with a few sessions of standard care, as compared to standard care alone.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The goal of this study is to explore if the SynPhNe system can be used easily at home for people who suffered a stroke. With this study, we are also investigating if the SynPhNe system used could improve your hand function when it is used with a few sessions of research therapy.
SynPhNe is a non-invasive device. It consists of a piece worn around the forearm, a head component and it communicates wirelessly via Bluetooth with the computer to provide subject with feedback while performing motor tasks with their hand. The head cap records your brain activity and gives feedback to help relaxing while exercising.
We are combining the use of the device with a research oriented rehabilitation program in a supervised environment. The SynPhNe system has not been approved by the U.S. Food and Drug Administration.
Subjects will be randomized by chance (like a coin toss) to one of the two groups: lab-based upper extremity research therapy alone or lab-based upper extremity research therapy in addition to the SynPhNe system for home-based exercises.
- The lab-based upper-extremity research therapy in its content is similar to regular occupational therapy and will focus exercise movements of arm and hand.
- The group testing the SynPhNe system at home will have the system lent at no cost.
The study last for up to 12 weeks and involves up to 22 sessions in total:
- Up to 3 sessions will be for testing arm movements (at baseline, after research therapy and at 1 month follow-up).
- 18 research therapy sessions. 10 of them will be done at Spaulding Rehabilitation Hospital with a therapist and 8 of them by yourself, at home. Subjects will either be using the SynPhNe system or use the therapy plan recommended by the therapist, depending on the randomization. Each of these visits will be an hour long. They will be scheduled 3 days per week for six weeks.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02129
- Spaulding Rehabilitation Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ischemic or hemorrhagic stroke at least 6 months prior study enrollment ;
- Moderate upper-extremity hemiparesis (initial score on the Upper Extremity Fugl-Meyer Assessment between 21 and 55 out of 66) ;
- Ability to extend at least 2 fingers in the affected hand 10 degrees at any joint with pain-free passive range of motion at least 50% in all joints below the elbow.
Exclusion Criteria:
- Cognitive impairment resulting to inability to follow instructions (as assessed with the MMSE) and inability to sustain attention for more than 10 minutes;
- Current participation in upper-extremity therapy program;
- Treatment with Botox injections in the affected arm in the previous 3 months and no planned Botox injections before the end of the study;
- Poor sitting balance (as assessed with the Berg Balance Test);
- Aphasia sufficient to limit comprehension and completion of the treatment protocol;
- No more than moderate impairments in paretic UE sensation, passive range of motion, and pain that would limit ability to engage in therapy;
- Increased muscle tone as indicated by score of >/= 3 on the Modified Ashworth Scale;
- Previous diagnosis of dementia;
- Previous diagnosis of neurological diseases other than Stroke;
- History of seizures disorder and/or a seizure occuring within the last 6 months;
- Other conditions affecting function of the stroke affected upper limb;
- Severe pain in the stroke affected upper limb;
- Terminal diseases with expected survival <1 year;
- Not able to provide us or give us access to brain imaging of their Stroke lesion.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SynPhNe therapy
Subjects will be asked to participate in a program of 18 upper-extremity rehabilitation sessions of 60 minutes with SynPhNe platform, over 6 weeks. The sessions will emphasize on the wrist and fingers movements, including functional activities. During week the two first weeks, 6 sessions will be done under therapist supervision at the Motion Analysis Laboratory at Spaulding Rehabilitation Hospital. Over the next 4 to 5 weeks, 10 sessions following exercises prompted by the SynPhNe system will be done unsupervised at home (or under limited supervision at the hospital), 2 sessions will be done at Spaulding Rehabilitation Hospital to review exercises with the SynPhNe system. |
SynPhNe is a non-invasive device.
It consists of a piece worn around the forearm, a head component and it communicates wirelessly with the computer to provide feedback while performing motor tasks with the hemiparetic hand.
The head cap records brain activity and gives feedback to help relaxing while exercising.
The arm and the head component communicate wirelessly with the computer via Bluetooth.
The head component reads brain signals while the arm gear senses your muscle signals when performing the exercises.
The computer software adopts the appropriate difficulty level, speed and duration of the exercise depending on brain and muscle status to minimize fatigue.
|
Active Comparator: Conventional therapy
Subjects will be asked to participate in a program of 18 upper-extremity rehabilitation sessions of 60 minutes under therapist supervision over two weeks at the Motion Analysis Laboratory at Spaulding Rehabilitation Hospital. The sessions will emphasize on the wrist and fingers movements, including functional activities. During week the two first weeks, 6 sessions will be done under therapist supervision at the Motion Analysis Laboratory at Spaulding Rehabilitation Hospital. The remaining 10 sessions will be done unsupervised at home, over approximately 4 weeks, and following the therapist home treatment plan. Over that time, 2 visits to Spaulding Rehabilitation will be made to review home treatment plan. Over the course of the study, participants will wear GeneActiv sensors to gather information about upper-extremity usage. |
Exercise program established with a therapist (8 sessions under therapist direct supervision and 10 sessions at home).
Low functioning subjects will be given more proximal joint-muscle exercises and activities while higher functioning subjects will have a greater component of distal tasks and activities.
The therapist will review the exercises therapy plan with the subject and re-adjust it.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fugl-Meyer Upper Extremity
Time Frame: Changes from baseline Fugl-Meyer scores at 7 weeks and at one month follow-up
|
FM-UE is a measure of upper-extremity motor impairment including coordination and speed.
|
Changes from baseline Fugl-Meyer scores at 7 weeks and at one month follow-up
|
Box and Block test
Time Frame: Changes from baseline scores at 7 week and at one month follow-up
|
Gross motor manual dexterity assessment
|
Changes from baseline scores at 7 week and at one month follow-up
|
Wolf Motor Function Test (Upper Extremity)
Time Frame: Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
of 17 items that are upper extremity motor tasks and that can assess movement components required for daily tasks.
|
Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Jamar dynamometer
Time Frame: Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Hand grip strength
|
Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Visual Analogue Scale for Pain
Time Frame: Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Assessment of pain intensity from 0 (no pain) to 10 (worse pain experienced)
|
Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Modified Ashworth Scale
Time Frame: Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Measure of spasticity of Upper Extremity, score range from 0 (no spasticity) to 4 (Passive movement no possible)
|
Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Systolic and Diastolic Blood Pressure
Time Frame: Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Arm measured blood Pressure
|
Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Motor Activity Log
Time Frame: Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Measure of amount and quality of arm use in daily life
|
Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
EQ5D questionnaire
Time Frame: Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Assessment of Quality of life
|
Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Goniometry - Active Range of Motion
Time Frame: Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Upper-extremity range of motion
|
Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Manual Muscle Testing (Kendall)
Time Frame: Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Muscle strength assessed by a therapist following Kendall guidelines.
Scores range from 0 (no contraction) to 5 (maximum strength)
|
Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
WHO-ICF problem solving form
Time Frame: Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Identification of participant's problems at the function, activity and environmental factors levels, following the World Health Organization International Classification of Functioning Codes.
Decrease in number of problems identified at baseline indicates better outcomes.
|
Changes from baseline scores at Baseline, at 7 weeks and at one month follow-up
|
Device satisfaction feedback questionnaire (only for intervention group)
Time Frame: Scores at 7 weeks
|
Questionnaire to gather satisfaction feedback about usage of the device.
Questions are scored from 1 to 5, total score up to 25.
Higher score indicate higher satisfaction with the device.
|
Scores at 7 weeks
|
Number of sessions completed (only for intervention group)
Time Frame: Scores at 7 weeks
|
Log of completed sessions by the software.
Higher number indicates better adherence to the intervention.
|
Scores at 7 weeks
|
Number of issues encountered with the device and/or software (only for intervention group)
Time Frame: Scores at 7 weeks
|
Number of occurrences of device and/or software malfunction.
|
Scores at 7 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-P-000666
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
Clinical Trials on SynPhNe platform
-
National University Hospital, SingaporeSynPhNe Pte Ltd.Recruiting
-
Kafrelsheikh UniversityCompletedPeri-implant Mucositis | Dental Implant FailedEgypt
-
Universidade Federal de PernambucoUnknownExercise | Kidney TransplantationBrazil
-
Aristotle University Of ThessalonikiRegion Stockholm; Hospital Universitario La Fe; University of GlasgowCompleted
-
Baylor College of MedicineBioSensicsRecruitingCognitive Impairment | Dementia | Mild Cognitive Impairment | Memory LossUnited States
-
University of GeorgiaEmory UniversityActive, not recruitingCerebral Palsy, SpasticUnited States
-
Sun Yat-sen UniversityRecruiting
-
University of LouisvilleCompleted
-
Reproductive Medicine Associates of New JerseyCompleted
-
Universidade Estadual do Norte do ParanáConselho Nacional de Desenvolvimento Científico e TecnológicoRecruitingEffects of Whole Body Vibration in Different Devices on Bone and Muscle Mass in Postmenopausal WomenQuality of Life | Physical Functional Performance | Bone Density | Accidental Falls | MusclesBrazil